Atom Therapeutics, a clinical stage biotechnology company developing best-in-class treatments for inflammatory and metabolic diseases, today announced FDA approval of a Phase II clinical trial ...

This increased risk held across all individual components of the composite ASCVD endpoint (coronary artery disease, ...

Current medical screening techniques could be failing to catch nearly half of those who experience a heart attack, according ...

The FDA approved Lerochol, a monthly PCSK9 inhibitor, for adults with hypercholesterolemia to reduce LDL-C levels alongside diet and exercise.

Presence of uterine fibroids was associated with increased risk for atherosclerotic heart disease compared with absence of ...

There is increasing evidence that gum disease is associated with increased risk of cardiovascular events, including heart ...

Effective prevention and treatment of gum disease, also called periodontal disease, could potentially decrease the burden of cardiovascular disease, according to a new scientific statement published ...

Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population.

Researchers found that consuming foods rich in polyphenols — such as coffee, berries, cocoa, and olive oil — may help improve ...

Uterine fibroids are associated with an increased risk for atherosclerotic cardiovascular disease (ASCVD) up to 10 years after diagnosis.

The larger risk reductions were not explained by changes in LDL cholesterol, suggesting something else is at play.

There is increasing evidence that gum disease is associated with increased risk of cardiovascular events, including heart ...